On September 15, 2023, Dr. Vijay Modur, Head of Research and Development of Eloxx Pharmaceuticals, Inc., notified the Company of his resignation effective September 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 USD | -4.83% |
|
+1.47% | -42.50% |
1st Jan change | Capi. | |
---|---|---|
-42.50% | 2.28M | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.18% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- ELOX Stock
- News Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals, Inc. Announces Resignation of Vijay Modur as Head of Research and Development